Kirk Look

Kirk Look

Chief Financial OfficeratOncolytics Biotech· In proxies 2024–2025

Pay in FY2025+67% from the year before · Oncolytics Biotech stock -4.4% the same year

Kirk Look was paid $1.1M in FY2025 (Dec), up 67%. Oncolytics Biotech stock fell 4.4% that year.

Pay$100 in the stock at the end of FY23 → $65
Pay is from the Summary Compensation Table of each Oncolytics Biotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oncolytics BiotechPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role -65%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?